Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
MW
Milky Way Biotech ApS
aktivCVR 44005255AnpartsselskabCentrifugevej 374, 2800 Kongens LyngbyForskning og eksperimentel udvikling inden for naturvidenskab og teknik
- Latest accounts
- 2024
- Statement scope
- Standalone
- Verified
- 05 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2024
Revenue
Data quality concern—
Data quality concern
Operating profit
Data quality concern—
Data quality concern
Net result
DKK -7.5k
Latest period
Source details
Source: dk-regnskabsdata-live-44005255-1793892449071
Document: dk-regnskabsdata-44005255-AZJJuWu1TzZH_GM9G6nr-1
XBRL: e:ProfitLoss
Period: 17 Apr 2023 - 30 Apr 2024
Technical details
Context: c1
Unit: u3
Equity
DKK 32.5k
Equity ratio: 23.7%
Source details
Source: dk-regnskabsdata-live-44005255-1793892449071
Document: dk-regnskabsdata-44005255-AZJJuWu1TzZH_GM9G6nr-1
XBRL: e:Equity
Period: 17 Apr 2023 - 30 Apr 2024
Technical details
Context: c45
Unit: u3
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2024 | — | DKK -7.5k |